News
RAHWAY, N.J., June 09, 2025--Merck Announces Positive Topline Results from Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for the Treatment of Adults with Hyperlipidemia ...
ABB has added to its Baldor-Reliance food safe stainless steel motor product portfolio with a three-lead electrical connection design. The Baldor-Reliance Food Safe stainless steel product lineup, ...
Sprunki MSI Phase 3 represents a thrilling progression in the Sprunki narrative, diving deeper into the darker and more intricate lore established in earlier chapters. 👉👉 Sprunki MSI Phase 3 This ...
Mumbai Metro Line 3 Inauguration: Mumbai’s first fully underground Metro corridor, the Aqua Line (Line 3), is set to welcome commuters on its second operational stretch, Phase 2A, which connects the ...
Based on the results in the EDS subgroup, Axsome plans to initiate a Phase 3 trial in MDD patients with EDS in 2025. The PARADIGM study was a 6-week, randomized, double-blind, placebo-controlled, ...
The TIDA-010936 reference design features a compact three-phase inverter using three 100V, 35A half-bridge GaN power modules. These modules integrate the driver and two 80V GaN FETs in a small 5.5mm × ...
Immunovant is yet to start a phase 3 trial of IMVT-1402 in myasthenia gravis. The biotech confirmed IMVT-1402 is its lead candidate in CIDP after getting a look at phase 2b data on batoclimab in ...
Green racing is getting a green flag, with an assist from a firm in Edgecombe County. Last week, a prototype for the first electricity-powered NASCAR race car was displayed at ABB in Pinetops ...
A power-conversion system for converting three-phase power into single-phase power is proposed in this paper. The proposed three-phase to single-phase (3φ/1φ) power-conversion system comprises a power ...
With the increasing integration of renewable energy sources (RES) and single-phase loads, three-phase imbalance and transformer lightly/heavily loaded operation issues has become more prominent in low ...
Trial Name: A Multicenter, Randomized, Phase 3 Study to Assess the Efficacy and Safety of INtratumorally Administered INT230-6 (SHAO, VINblastine, CIsplatin) Compared With US Standard of Care in ...
Background: Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) remains a standard of care first-line (1L) treatment for patients (pts) with DLBCL. However, poor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results